These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12069112)

  • 1. Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia.
    Rustin P; Rötig A; Munnich A; Sidi D
    Free Radic Res; 2002 Apr; 36(4):467-9. PubMed ID: 12069112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.
    Hausse AO; Aggoun Y; Bonnet D; Sidi D; Munnich A; Rötig A; Rustin P
    Heart; 2002 Apr; 87(4):346-9. PubMed ID: 11907009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring.
    Buyse G; Mertens L; Di Salvo G; Matthijs I; Weidemann F; Eyskens B; Goossens W; Goemans N; Sutherland GR; Van Hove JL
    Neurology; 2003 May; 60(10):1679-81. PubMed ID: 12771265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study.
    Rustin P; von Kleist-Retzow JC; Chantrel-Groussard K; Sidi D; Munnich A; Rötig A
    Lancet; 1999 Aug; 354(9177):477-9. PubMed ID: 10465173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights into Friedreich's ataxia and antioxidant-based therapies.
    Rötig A; Sidi D; Munnich A; Rustin P
    Trends Mol Med; 2002 May; 8(5):221-4. PubMed ID: 12067631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful idebenone therapy of hypertrophic cardiomyopathy in Friedreich ataxia].
    Kádár K
    Orv Hetil; 2003 Jun; 144(25):1241-4. PubMed ID: 12901180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial.
    Mariotti C; Solari A; Torta D; Marano L; Fiorentini C; Di Donato S
    Neurology; 2003 May; 60(10):1676-9. PubMed ID: 12771264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
    Di Prospero NA; Baker A; Jeffries N; Fischbeck KH
    Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA).
    Lagedrost SJ; Sutton MS; Cohen MS; Satou GM; Kaufman BD; Perlman SL; Rummey C; Meier T; Lynch DR
    Am Heart J; 2011 Mar; 161(3):639-645.e1. PubMed ID: 21392622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.
    Lodi R; Rajagopalan B; Bradley JL; Taylor DJ; Crilley JG; Hart PE; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Free Radic Res; 2002 Apr; 36(4):461-6. PubMed ID: 12069111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Friedreich's ataxia: idebenone treatment in early stage patients.
    Artuch R; Aracil A; Mas A; Colomé C; Rissech M; Monrós E; Pineda M
    Neuropediatrics; 2002 Aug; 33(4):190-3. PubMed ID: 12368988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idebenone in Friedreich's ataxia.
    Tonon C; Lodi R
    Expert Opin Pharmacother; 2008 Sep; 9(13):2327-37. PubMed ID: 18710357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
    Cooper JM; Schapira AH
    Biofactors; 2003; 18(1-4):163-71. PubMed ID: 14695932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring cardiac function during idebenone therapy in Friedreich's ataxia.
    Giovanni DS; Valeria P; Bahaa F; Majid AF
    Curr Pharm Des; 2015; 21(4):479-83. PubMed ID: 25483949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
    Seznec H; Simon D; Monassier L; Criqui-Filipe P; Gansmuller A; Rustin P; Koenig M; Puccio H
    Hum Mol Genet; 2004 May; 13(10):1017-24. PubMed ID: 15028670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
    Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
    Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia.
    Di Prospero NA; Sumner CJ; Penzak SR; Ravina B; Fischbeck KH; Taylor JP
    Arch Neurol; 2007 Jun; 64(6):803-8. PubMed ID: 17562928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.
    Velasco-Sánchez D; Aracil A; Montero R; Mas A; Jiménez L; O'Callaghan M; Tondo M; Capdevila A; Blanch J; Artuch R; Pineda M
    Cerebellum; 2011 Mar; 10(1):1-8. PubMed ID: 20865357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idebenone: an emerging therapy for Friedreich ataxia.
    Meier T; Buyse G
    J Neurol; 2009 Mar; 256 Suppl 1():25-30. PubMed ID: 19283347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idebenone in patients with Friedreich ataxia.
    Schöls L; Vorgerd M; Schillings M; Skipka G; Zange J
    Neurosci Lett; 2001 Jun; 306(3):169-72. PubMed ID: 11406322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.